메뉴 건너뛰기




Volumn 124, Issue 10, 2014, Pages 4363-4374

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MELITTIN; MELITTIN DERIVED CATIONIC AMPHIPATHIC PEPTIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NANOCOMPOSITE; NFKB1 PROTEIN, MOUSE; PEPTIDE; RELA PROTEIN, MOUSE;

EID: 84907482356     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75673     Document Type: Article
Times cited : (81)

References (44)
  • 1
    • 70350513270 scopus 로고    scopus 로고
    • Regulation of tissue homeostasis by NF-κB signalling: Implications for inflammatory diseases
    • Pasparakis M. Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases. Nat Rev Immunol. 2009;9(11):778-788.
    • (2009) Nat Rev Immunol. , vol.9 , Issue.11 , pp. 778-788
    • Pasparakis, M.1
  • 2
    • 84855172814 scopus 로고    scopus 로고
    • The pathogenesis of rheumatoid arthritis
    • McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-2219.
    • (2011) N Engl J Med. , vol.365 , Issue.23 , pp. 2205-2219
    • McInnes, I.B.1    Schett, G.2
  • 5
    • 84858213225 scopus 로고    scopus 로고
    • Biologic agents in rheumatoid arthritis: An update for managed care professionals
    • Agarwal SK. Biologic agents in rheumatoid arthritis: an update for managed care professionals. J Manag Care Pharm. 2011;17(9):S14-S18.
    • (2011) J Manag Care Pharm. , vol.17 , Issue.9 , pp. S14-S18
    • Agarwal, S.K.1
  • 6
    • 34447336406 scopus 로고    scopus 로고
    • Longterm infliximab treatment in rheumatoid arthritis: Subsequent outcome of initial responders
    • Buch MH, Bingham SJ, Bryer D, Emery P. Longterm infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders. Rheumatology (Oxford). 2007;46(7):1153-1156.
    • (2007) Rheumatology (Oxford). , vol.46 , Issue.7 , pp. 1153-1156
    • Buch, M.H.1    Bingham, S.J.2    Bryer, D.3    Emery, P.4
  • 7
    • 84879806081 scopus 로고    scopus 로고
    • Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis
    • Feist E, Burmester GR. Small molecules targeting JAKs-a new approach in the treatment of rheumatoid arthritis. Rheumatology (Oxford). 2013;52(8):1352-1357.
    • (2013) Rheumatology (Oxford). , vol.52 , Issue.8 , pp. 1352-1357
    • Feist, E.1    Burmester, G.R.2
  • 8
    • 42949171833 scopus 로고    scopus 로고
    • Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation
    • Simmonds RE, Foxwell BM. Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation. Rheumatology (Oxford). 2008;47(5):584-590.
    • (2008) Rheumatology (Oxford). , vol.47 , Issue.5 , pp. 584-590
    • Simmonds, R.E.1    Foxwell, B.M.2
  • 9
    • 59449108567 scopus 로고    scopus 로고
    • The roles of the classical and alternative nuclear factorkappaB pathways: Potential implications for autoimmunity and rheumatoid arthritis
    • Brown KD, Claudio E, Siebenlist U. The roles of the classical and alternative nuclear factorkappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther. 2008;10(4):212.
    • (2008) Arthritis Res Ther. , vol.10 , Issue.4 , pp. 212
    • Brown, K.D.1    Claudio, E.2    Siebenlist, U.3
  • 10
    • 73249147432 scopus 로고    scopus 로고
    • Gene discovery in rheumatoid arthritis highlights the CD40/NF-κB signaling pathway in disease pathogenesis
    • Criswell LA. Gene discovery in rheumatoid arthritis highlights the CD40/NF-κB signaling pathway in disease pathogenesis. Immunol Rev. 2010;233(1):55-61.
    • (2010) Immunol Rev. , vol.233 , Issue.1 , pp. 55-61
    • Criswell, L.A.1
  • 11
    • 82455162312 scopus 로고    scopus 로고
    • Negative regulation of NF-kappaB and its involvement in rheumatoid arthritis
    • Van Loo G, Beyaert R. Negative regulation of NF-kappaB and its involvement in rheumatoid arthritis. Arthritis Res Ther. 2011;13(3):221.
    • (2011) Arthritis Res Ther. , vol.13 , Issue.3 , pp. 221
    • Van Loo, G.1    Beyaert, R.2
  • 12
    • 38849199203 scopus 로고    scopus 로고
    • Shared principles in NF-κB signaling
    • Hayden MS, Ghosh S. Shared principles in NF-κB signaling. Cell. 2008;132(3):344-362.
    • (2008) Cell , vol.132 , Issue.3 , pp. 344-362
    • Hayden, M.S.1    Ghosh, S.2
  • 13
    • 84873433098 scopus 로고    scopus 로고
    • Melittin derived peptides for nanoparticle based siRNA transfection
    • Hou KK, Pan H, Lanza GM, Wickline SA. Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials. 2013;34(12):3110-3119.
    • (2013) Biomaterials. , vol.34 , Issue.12 , pp. 3110-3119
    • Hou, K.K.1    Pan, H.2    Lanza, G.M.3    Wickline, S.A.4
  • 14
    • 84887009773 scopus 로고    scopus 로고
    • Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides
    • Hou KK, Pan H, Ratner L, Schlesinger PH, Wickline SA. Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. AC S Nano. 2013;7(10):8605-8615.
    • (2013) AC S Nano. , vol.7 , Issue.10 , pp. 8605-8615
    • Hou, K.K.1    Pan, H.2    Ratner, L.3    Schlesinger, P.H.4    Wickline, S.A.5
  • 15
    • 0014670341 scopus 로고
    • Interaction of alytic polypeptide, melittin, with lipid membrane systems
    • Sessa G, Freer JH, Colacicco G, Weissmann G. Interaction of alytic polypeptide, melittin, with lipid membrane systems. J Biol Chem. 1969;244(13):3575-3582.
    • (1969) J Biol Chem. , vol.244 , Issue.13 , pp. 3575-3582
    • Sessa, G.1    Freer, J.H.2    Colacicco, G.3    Weissmann, G.4
  • 16
    • 77955802263 scopus 로고    scopus 로고
    • Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures
    • Pan H, et al. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J. 2010;24(8):2928-2937.
    • (2010) FASEB J. , vol.24 , Issue.8 , pp. 2928-2937
    • Pan, H.1
  • 17
    • 0018830639 scopus 로고
    • Immunisation against heterologous type II collagen induces arthritis in mice
    • Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980;283(5748):666-668.
    • (1980) Nature , vol.283 , Issue.5748 , pp. 666-668
    • Courtenay, J.S.1    Dallman, M.J.2    Dayan, A.D.3    Martin, A.4    Mosedale, B.5
  • 18
    • 0022295359 scopus 로고
    • Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci
    • Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med. 1985;162(6):1878-1891.
    • (1985) J Exp Med. , vol.162 , Issue.6 , pp. 1878-1891
    • Watson, W.C.1    Townes, A.S.2
  • 20
    • 84872405597 scopus 로고    scopus 로고
    • In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier
    • Naeye B, et al. In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier. Biomaterials. 2013;34(9):2350-2358.
    • (2013) Biomaterials. , vol.34 , Issue.9 , pp. 2350-2358
    • Naeye, B.1
  • 21
    • 78650943096 scopus 로고    scopus 로고
    • Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces
    • Pham CT, et al. Variable antibody-dependent activation of complement by functionalized phospholipid nanoparticle surfaces. J Biol Chem. 2011;286(1):123-130.
    • (2011) J Biol Chem. , vol.286 , Issue.1 , pp. 123-130
    • Pham, C.T.1
  • 22
    • 84896542810 scopus 로고    scopus 로고
    • Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles
    • Pham CT, et al. Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles. Nanomedicine. 2014;10(3):651-660.
    • (2014) Nanomedicine. , vol.10 , Issue.3 , pp. 651-660
    • Pham, C.T.1
  • 23
    • 9144219693 scopus 로고    scopus 로고
    • An efficient proteomics method to identify the cellular targets of protein kinase inhibitors
    • Godl K, et al. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci U S A. 2003;100(26):15434-15439.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , Issue.26 , pp. 15434-15439
    • Godl, K.1
  • 24
    • 79954580272 scopus 로고    scopus 로고
    • Current prospects for RNA interference-based therapies
    • Davidson BL, McCray PB, McCray PB Jr. Current prospects for RNA interference-based therapies. Nat Rev Genet. 2011;12(5):329-340.
    • (2011) Nat Rev Genet. , vol.12 , Issue.5 , pp. 329-340
    • Davidson, B.L.1    McCray, P.B.2    Mccray, P.B.3
  • 25
    • 17244378648 scopus 로고    scopus 로고
    • Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis
    • Schiffelers RM, Xu J, Storm G, Woodle MC, Scaria PV. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Ar thritis Rheum. 2005;52(4):1314-1318.
    • (2005) Ar Thritis Rheum. , vol.52 , Issue.4 , pp. 1314-1318
    • Schiffelers, R.M.1    Xu, J.2    Storm, G.3    Woodle, M.C.4    Scaria, P.V.5
  • 26
    • 33745014998 scopus 로고    scopus 로고
    • Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis
    • Khoury M, et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum. 2006;54(6):1867-1877.
    • (2006) Arthritis Rheum. , vol.54 , Issue.6 , pp. 1867-1877
    • Khoury, M.1
  • 27
    • 49549101615 scopus 로고    scopus 로고
    • Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes
    • Khoury M, et al. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes. Arthritis Rheum. 2008;58(8):2356-2367.
    • (2008) Arthritis Rheum. , vol.58 , Issue.8 , pp. 2356-2367
    • Khoury, M.1
  • 28
    • 84892424496 scopus 로고    scopus 로고
    • Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis
    • Zhang T, Bai X, Mao X. Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis. PLoS One. 2013;8(11):e78619.
    • (2013) PLoS One. , vol.8 , Issue.11 , pp. e78619
    • Zhang, T.1    Bai, X.2    Mao, X.3
  • 29
    • 84895903061 scopus 로고    scopus 로고
    • TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis
    • Lee SJ, et al. TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther. 2014;22(2):397-408.
    • (2014) Mol Ther. , vol.22 , Issue.2 , pp. 397-408
    • Lee, S.J.1
  • 30
    • 84903782299 scopus 로고    scopus 로고
    • Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis
    • Duan J, et al. Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis. Nanomedicine (Lond). 2014;9(6):789-801.
    • (2014) Nanomedicine (Lond). , vol.9 , Issue.6 , pp. 789-801
    • Duan, J.1
  • 31
    • 33746438424 scopus 로고    scopus 로고
    • Toxicity of cationic lipids and cationic polymers in gene delivery
    • Lv H, Zhang S, Wang B, Cui S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. 2006;114(1):100-109.
    • (2006) J Control Release. , vol.114 , Issue.1 , pp. 100-109
    • Lv, H.1    Zhang, S.2    Wang, B.3    Cui, S.4    Yan, J.5
  • 32
    • 67349267016 scopus 로고    scopus 로고
    • Addressing the problem of cationic lipid-mediated toxicity: The magnetoliposome model
    • Soenen SJ, Brisson AR, De Cuyper M. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials. 2009;30(22):3691-3701.
    • (2009) Biomaterials. , vol.30 , Issue.22 , pp. 3691-3701
    • Soenen, S.J.1    Brisson, A.R.2    De Cuyper, M.3
  • 34
    • 0029789793 scopus 로고    scopus 로고
    • Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery
    • Plank C, Mechtler K, Szoka FC, Szoka FC Jr, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther. 1996;7(12):1437-1446.
    • (1996) Hum Gene Ther. , vol.7 , Issue.12 , pp. 1437-1446
    • Plank, C.1    Mechtler, K.2    Szoka, F.C.3    Szoka, F.C.4    Wagner, E.5
  • 35
    • 0021701974 scopus 로고
    • The activation of the complement system by polymer materials and their blood compatibility
    • Sevast'ianov VI, Tseytlina EA. The activation of the complement system by polymer materials and their blood compatibility. J Biomed Mater Res. 1984;18(9):969-978.
    • (1984) J Biomed Mater Res. , vol.18 , Issue.9 , pp. 969-978
    • Sevast'ianov, V.I.1    Tseytlina, E.A.2
  • 37
    • 84859031194 scopus 로고    scopus 로고
    • Postformulation peptide drug loading of nanostructures
    • Pan H, et al. Postformulation peptide drug loading of nanostructures. Methods Enzymol. 2012;508:17-39.
    • (2012) Methods Enzymol. , vol.508 , pp. 17-39
    • Pan, H.1
  • 38
    • 84871868348 scopus 로고    scopus 로고
    • Programmable nanoparticle functionalization for in vivo targeting
    • Pan H, et al. Programmable nanoparticle functionalization for in vivo targeting. FASEB J. 2013;27(1):255-264.
    • (2013) FASEB J. , vol.27 , Issue.1 , pp. 255-264
    • Pan, H.1
  • 39
    • 44449136550 scopus 로고    scopus 로고
    • Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides
    • Soman NR, Lanza GM, Heuser JM, Schlesinger PH, Wickline SA. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. Nano Le tt. 2008;8(4):1131-1136.
    • (2008) Nano le tt. , vol.8 , Issue.4 , pp. 1131-1136
    • Soman, N.R.1    Lanza, G.M.2    Heuser, J.M.3    Schlesinger, P.H.4    Wickline, S.A.5
  • 40
    • 70349220917 scopus 로고    scopus 로고
    • Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
    • Soman NR, et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest. 2009;119(9):2830-2842.
    • (2009) J Clin Invest. , vol.119 , Issue.9 , pp. 2830-2842
    • Soman, N.R.1
  • 41
    • 80155200721 scopus 로고    scopus 로고
    • Therapeutic siRNA silencing in inflammatory monocytes in mice
    • Leuschner F, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol. 2011;29(11):1005-1010.
    • (2011) Nat Biotechnol. , vol.29 , Issue.11 , pp. 1005-1010
    • Leuschner, F.1
  • 42
    • 70349334687 scopus 로고    scopus 로고
    • Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice
    • Zhou HF, Chan HW, Wickline SA, Lanza GM, Pham CT. Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J. 2009;23(9):2978-2985.
    • (2009) FASEB J. , vol.23 , Issue.9 , pp. 2978-2985
    • Zhou, H.F.1    Chan, H.W.2    Wickline, S.A.3    Lanza, G.M.4    Pham, C.T.5
  • 43
    • 77957562101 scopus 로고    scopus 로고
    • Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis
    • Zhou HF, Hu G, Wickline SA, Lanza GM, Pham CT. Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis. Nanomedicine (Lond). 2010;5(7):1065-1074.
    • (2010) Nanomedicine (Lond). , vol.5 , Issue.7 , pp. 1065-1074
    • Zhou, H.F.1    Hu, G.2    Wickline, S.A.3    Lanza, G.M.4    Pham, C.T.5
  • 44
    • 0036168150 scopus 로고    scopus 로고
    • Dipeptidyl peptidase I activates neutrophilderived serine proteases and regulates the development of acute experimental arthritis
    • Adkison AM, Raptis SZ, Kelley DG, Pham CT. Dipeptidyl peptidase I activates neutrophilderived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest. 2002;109(3):363-371.
    • (2002) J Clin Invest. , vol.109 , Issue.3 , pp. 363-371
    • Adkison, A.M.1    Raptis, S.Z.2    Kelley, D.G.3    Pham, C.T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.